| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2012 | US20120129868 Poly (adp-ribose) polymerase (parp) inhibitors |
| 05/24/2012 | US20120129867 Inhibitors of protein kinases |
| 05/24/2012 | US20120129866 Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma |
| 05/24/2012 | US20120129865 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt |
| 05/24/2012 | US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same |
| 05/24/2012 | US20120129863 Chymase inhibitors |
| 05/24/2012 | US20120129862 Prokineticin 1 receptor antagonists |
| 05/24/2012 | US20120129860 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 05/24/2012 | US20120129859 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1h)pyridone compounds and salts thereof and their applications |
| 05/24/2012 | US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
| 05/24/2012 | US20120129857 Substituted sodium 1H-pyrazol-5-olate |
| 05/24/2012 | US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation |
| 05/24/2012 | US20120129855 Phthalazinone derivatives |
| 05/24/2012 | US20120129854 Pesticidal Arylpyrrolidines |
| 05/24/2012 | US20120129853 Methods of treatment using selective bcl-2 inhibitors |
| 05/24/2012 | US20120129852 Azaindazoles as kinase inhibitors and use thereof |
| 05/24/2012 | US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives |
| 05/24/2012 | US20120129850 Imidazolothiazole compounds for the treatment of disease |
| 05/24/2012 | US20120129849 Deuterated serine-threonine protein kinase modulators |
| 05/24/2012 | US20120129848 Benzo [E] [1,3] Oxazin-4-One Derivatives as Phosphoinositide 3-Kinase Inhibitors |
| 05/24/2012 | US20120129847 Compositions and methods for treating ocular edema, neovascularization and related diseases |
| 05/24/2012 | US20120129846 Gamma secretase modulators |
| 05/24/2012 | US20120129845 Inhibitors of Bruton's Tyrosine Kinase |
| 05/24/2012 | US20120129844 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof |
| 05/24/2012 | US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129841 Carboline derivatives useful in the treatment of cancer and other diseases |
| 05/24/2012 | US20120129840 Novel viral replication inhibitors |
| 05/24/2012 | US20120129839 Methods of treating disorders associated with protein polymerization |
| 05/24/2012 | US20120129838 Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient |
| 05/24/2012 | US20120129837 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof |
| 05/24/2012 | US20120129836 Imidazole derivatives as PDE10A enzyme inhibitors |
| 05/24/2012 | US20120129835 Schizophrenia methods and compositions |
| 05/24/2012 | US20120129834 Serotonin receptor antagonists for use in the treatment of huntington's disease |
| 05/24/2012 | US20120129833 Cyclic ketoenols for therapy |
| 05/24/2012 | US20120129832 Amide derivative |
| 05/24/2012 | US20120129831 Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-Phenylpiperidines |
| 05/24/2012 | US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 05/24/2012 | US20120129829 Novel indole modulators of s1p receptors |
| 05/24/2012 | US20120129828 S1p1 receptor agonists and use thereof |
| 05/24/2012 | US20120129827 Novel derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds |
| 05/24/2012 | US20120129826 Method of Treating Depression |
| 05/24/2012 | US20120129825 Method for on-demand contraception using levonorgestrel or norgestrel |
| 05/24/2012 | US20120129824 Pharmaceutical Formulations Containing Corticosteroids for Topical Administration |
| 05/24/2012 | US20120129823 Contraception process and administration form for the same |
| 05/24/2012 | US20120129822 Composition containing diosgenin and use thereof to improve at least one of cognitive deficits associated with menopausal syndrome |
| 05/24/2012 | US20120129821 Inhibitors of bruton's tyrosine kinase |
| 05/24/2012 | US20120129820 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 05/24/2012 | US20120129819 Gel compositions for administration of pharmaceutically active compounds |
| 05/24/2012 | US20120129818 Compositions and Methods for Treatment of Cardiovascular Disease |
| 05/24/2012 | US20120129817 Combination treatment for diabetes mellitus |
| 05/24/2012 | US20120129816 Aryl sulfonamide amine compounds and their use as 5-ht6 ligands |
| 05/24/2012 | US20120129814 Novel phosphonic acids as s1p receptor modulators |
| 05/24/2012 | US20120129813 Novel compounds as receptor modulators with therapeutic utility |
| 05/24/2012 | US20120129812 Novel thyroid hormone beta receptor agonist |
| 05/24/2012 | US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129810 Combination antineoplastic therapy |
| 05/24/2012 | US20120129809 Lung cancer treatment |
| 05/24/2012 | US20120129808 Blood coagulation reaction inhibitor |
| 05/24/2012 | US20120129807 Methods of treatment, improvement and prevention using haloaryl substituted aminopurines |
| 05/24/2012 | US20120129806 Arginase inhibitors as therapeutics |
| 05/24/2012 | US20120129805 Barley and uses thereof |
| 05/24/2012 | US20120129804 Methods of reducing absorption of trans fatty acids using water-insoluble cellulose derivatives |
| 05/24/2012 | US20120129803 Composition containing chitooligosaccharide for recovering from fatigue |
| 05/24/2012 | US20120129802 Process for the production of ultrapure galacto-oligosaccharides |
| 05/24/2012 | US20120129801 Blood parasiticide |
| 05/24/2012 | US20120129800 Agent For Preventing And Treating Pityriasis Versicolor |
| 05/24/2012 | US20120129799 stable composition of ready-to-use gemcitabine injection |
| 05/24/2012 | US20120129798 Stealth polymeric particles for delivery of bioactive or diagnostic agents |
| 05/24/2012 | US20120129797 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization |
| 05/24/2012 | US20120129795 Antiviral compounds |
| 05/24/2012 | US20120129794 Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy |
| 05/24/2012 | US20120129793 Antimicrobial Polyether and Polyol Compounds |
| 05/24/2012 | US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders |
| 05/24/2012 | US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides |
| 05/24/2012 | US20120129775 Antiangiogenic small molecules and methods of use |
| 05/24/2012 | US20120129761 Preparation of bone cement compositions |
| 05/24/2012 | US20120129757 Compositions and methods for promoting vascular barrier function and treating pulonary fibrosis |
| 05/24/2012 | US20120129178 Genomic polymorphism for predicting therapeutic response |
| 05/24/2012 | US20120128843 Water and feed preservative |
| 05/24/2012 | US20120128805 Long-lasting gustatory and/or olfactory aversion veterinary compositions for behavior modification |
| 05/24/2012 | US20120128800 Dietary supplements containing extracts of aronia and method of using same to promote weight loss |
| 05/24/2012 | US20120128798 Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species |
| 05/24/2012 | US20120128797 Method for treatment of constipation-predominant irritable bowel syndrome |
| 05/24/2012 | US20120128796 Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss |
| 05/24/2012 | US20120128794 Methods and compositions for the sustained release of chromium |
| 05/24/2012 | US20120128793 Implantable or insertable medical device resistant to microbial growth and biofilm formation |
| 05/24/2012 | US20120128782 Multicomponent Degradable Cationic Polymers |
| 05/24/2012 | US20120128780 Nanoparticulate bisphosphonate compositions |
| 05/24/2012 | US20120128778 Compositions and methods for once-daily administration of a trilayer osmotic tablet |
| 05/24/2012 | US20120128777 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
| 05/24/2012 | US20120128775 Biocarrier and method of using the same |
| 05/24/2012 | US20120128773 Desfesoterodine in the form of a tartaric acid salt |
| 05/24/2012 | US20120128772 Controlled release pharmaceutical compositions of milnacipran |
| 05/24/2012 | US20120128770 Treatment of insulin resistance and obesity by stimulating glp-1 release |
| 05/24/2012 | US20120128769 Solubilized CoQ-10 |
| 05/24/2012 | US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 05/24/2012 | US20120128767 Therapeutic calcium phosphate particles and methods of making and using same |
| 05/24/2012 | US20120128766 Self-Breaking Tablets |
| 05/24/2012 | US20120128765 Method and device for producing soft capsules |